Abstract
Some new 1,4-disubstituted-sulfonyl-1,2,3-triazoles (3a–f, 5a–h, 7a–d, and 9a–e) were regioselectively synthesized in high yields by Cu(I) catalyzed 1,3-dipolar cycloaddition (DC) reaction of p-acetamidobenzenesulfonyl azide (p-ABSA) with terminal alkynes. These new triazole compounds were evaluated for in vitro antibacterial activity against a panel of Gram-positive Bacillus sphericus, Staphylococcus epidermidis, and Gram-negative Klebsiella pneumonia, Escherichia coli species. Several of these compounds were found to possess comparable growth inhibition activity with the commercial standards Penicillin-G and Streptomycin.
Similar content being viewed by others
References
Aher NG, Pore VS, Mishra NN, Kumar A, Shukla PK, Sharma A, Bhat MK (2009) Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues. Bioorg Med Chem Lett 19(3):759–763. doi:10.1016/j.bmcl.2008.12.026
Alvarez R, Velazquez S, San-Felix A, Aquaro S, Clercq ED, Perno C-F, Karlsson A, Balzarini J, Camarasa MJ (1994) 1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) analogs: synthesis and anti-HIV-1 activity. J Med Chem 37(24):4185–4194. doi:10.1021/jm00050a015
Banday AH, Shameem SA, Gupta BD, Kumar HMS (2010) D-ring substituted 1,2,3-triazolyl 20-keto pregnenanes as potential anticancer agents: synthesis and biological evaluation. Steroids 75(12):801–804. doi:10.1016/j.steroids.2010.02.015
Bock VD, Speijer D, Hiemstra H, van Maarseveen JH (2007) 1,2,3-Triazoles as peptide bond isosteres: synthesis and biological evaluation of cyclotetrapeptide mimics. Org Biomol Chem 5(6):971–975. doi:10.1039/B616751A
Brik A, Alexandratos J, Lin Y-C, Elder JH, Olson AJ, Wlodawer A, Goodsell DS, Wong C-H (2005) 1,2,3-Triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors. ChemBioChem 6(7):1167–1169. doi:10.1002/cbic.200500101
Buckle DR, Outred DJ, Rockell CJM, Smith H, Spicer BA (1983) Studies on v-triazoles. 7. Antiallergic 9-oxo-1H,9H-benzopyrano[2,3-d]-v-triazoles. J Med Chem 26(2):251–254. doi:10.1021/jm00356a025
Buckle DR, Rockell CJM, Smith H, Spicer BA (1986) Studies on 1,2,3-triazoles. 13. (Piperazinylalkoxy)-[1]benzopyrano[2,3-d]-1,2,3-triazol-9(1H)-ones with combined H1-antihistamine and mast cell stabilizing properties. J Med Chem 29(11):2262–2267. doi:10.1021/jm00161a022
Clardy J, Fischbach MA, Walsh CT (2006) New antibiotics from bacterial natural products. Nat Biotech 24(12):1541–1550
Costa MS, Boechat N, Rangel EA, da Silva Fde C, de Souza AM, Rodrigues CR, Castro HC, Junior IN, Lourenco MC, Wardell SM, Ferreira VF (2006) Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives. Bioorg Med Chem 14(24):8644–8653. doi:10.1016/j.bmc.2006.08.019
da Silva Fde C, de Souza MC, Frugulhetti II, Castro HC, Souza SL, de Souza TM, Rodrigues DQ, Souza AM, Abreu PA, Passamani F, Rodrigues CR, Ferreira VF (2009) Synthesis, HIV-RT inhibitory activity and SAR of 1-benzyl-1H-1,2,3-triazole derivatives of carbohydrates. Eur J Med Chem 44(1):373–383. doi:10.1016/j.ejmech.2008.02.047
Dahmani S, Kandri Rodi Y, Luis SV, Essassi el M, El Ammari L (2011) 1-Acetyl-6-bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one. Acta Crystallogr Sect E Struct Rep Online 67(Pt 6):o1375. doi:10.1107/S1600536811017004
De Simone R, Chini MG, Bruno I, Riccio R, Mueller D, Werz O, Bifulco G (2011) Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase−1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents. J Med Chem 54(6):1565–1575. doi:10.1021/jm101238d
Demaray JA, Thuener JE, Dawson MN, Sucheck SJ (2008) Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity. Bioorg Med Chem Lett 18(17):4868–4871. doi:10.1016/j.bmcl.2008.07.087
Ding C, Zhang Y, Chen H, Wild C, Wang T, White MA, Shen Q, Zhou J (2013) Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position. Org Lett 15(14):3718–3721. doi:10.1021/ol4015865
Fung-Tomc JC, Huczko E, Minassian B, Bonner DP (1998) In vitro activity of a new oral triazole, BMS-207147 (ER-30346). Antimicrob Agents Chemother 42(2):313–318
Giffin MJ, Heaslet H, Brik A, Lin YC, Cauvi G, Wong CH, McRee DE, Elder JH, Stout CD, Torbett BE (2008) A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. J Med Chem 51(20):6263–6270. doi:10.1021/jm800149m
Hein JE, Tripp JC, Krasnova LB, Sharpless KB, Fokin VV (2009) Copper(I)-catalyzed cycloaddition of organic azides and 1-iodoalkynes. Angew Chem Int Ed 48(43):8018–8021. doi:10.1002/anie.200903558
Kankala S, Kankala RK, Balaboina R, Thirukovela NS, Vadde R, Vasam CS (2014) Pd-N-heterocyclic carbene catalyzed synthesis of piperidine alkene–alkaloids and their anti-cancer evaluation. Bioorg Med Chem Lett 24(4):1180–1183. doi:10.1016/j.bmcl.2013.12.108
Kankala S, Kankala RK, Gundepaka P, Thota N, Nerella S, Gangula MR, Guguloth H, Kagga M, Vadde R, Vasam CS (2013) Regioselective synthesis of isoxazole–mercaptobenzimidazole hybrids and their in vivo analgesic and anti-inflammatory activity studies. Bioorg Med Chem Lett 23(5):1306–1309. doi:10.1016/j.bmcl.2012.12.101
Kankala S, Vadde R, Vasam CS (2011) N-Heterocyclic carbene-catalyzed 1,3-dipolar cycloaddition reactions: a facile synthesis of 3,5-di- and 3,4,5-trisubstituted isoxazoles. Org Biomol Chem 9(22):7869–7876. doi:10.1039/C1OB06072D
Kharb R, Yar MS, Sharma PC (2011) New insights into chemistry and anti-infective potential of triazole scaffold. Curr Med Chem 18(21):3265–3297
Kim DK, Kim J, Park HJ (2004) Synthesis and biological evaluation of novel 2-pyridinyl-[1,2,3]triazoles as inhibitors of transforming growth factor beta 1 type 1 receptor. Bioorg Med Chem Lett 14(10):2401–2405. doi:10.1016/j.bmcl.2004.03.024
Kirby WM, Yoshihara GM, Sundsted KS, Warren JH (1956) Clinical usefulness of a single disc method for antibiotic sensitivity testing. Antibiot Annu 1957:892–897
Lewis K (2013) Platforms for antibiotic discovery. Nat Rev Drug Discov 12(5):371–387. doi:10.1038/nrd3975
Li F, Park Y, Hah J-M, Ryu J-S (2013) Synthesis and biological evaluation of 1-(6-methylpyridin-2-yl)-5-(quinoxalin-6-yl)-1,2,3-triazoles as transforming growth factor-β type 1 receptor kinase inhibitors. Bioorg Med Chem Lett 23(4):1083–1086. doi:10.1016/j.bmcl.2012.12.008
Li X, Lin Y, Wang Q, Yuan Y, Zhang H, Qian X (2011) The novel anti-tumor agents of 4-triazol-1,8-naphthalimides: synthesis, cytotoxicity, DNA intercalation and photocleavage. Eur J Med Chem 46(4):1274–1279. doi:10.1016/j.ejmech.2011.01.050
Michaelidou AS, Hadjipavlou-Litina D (2005) Nonsteroidal anti-inflammatory drugs (NSAIDs): a comparative QSAR study. Chem Rev 105(9):3235–3271. doi:10.1021/cr040708m
Patpi SR, Pulipati L, Yogeeswari P, Sriram D, Jain N, Sridhar B, Murthy R, Anjana Devi T, Kalivendi SV, Kantevari S (2012) Design, synthesis, and structure-activity correlations of novel dibenzo[b,d]furan, dibenzo[b,d]thiophene, and N-methylcarbazole clubbed 1,2,3-triazoles as potent inhibitors of Mycobacterium tuberculosis. J Med Chem 55(8):3911–3922. doi:10.1021/jm300125e
Reddy DM, Srinivas J, Chashoo G, Saxena AK, Sampath Kumar HM (2011) 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation. Eur J Med Chem 46(6):1983–1991. doi:10.1016/j.ejmech.2011.02.016
Rostovtsev VV, Green LG, Fokin VV, Sharpless KB (2002a) A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes. Angew Chem 114(14):2708–2711. doi:10.1002/1521-3757(20020715)114:14<2708::AID-ANGE2708>3.0.CO;2-0
Shafi S, Mahboob Alam M, Mulakayala N, Mulakayala C, Vanaja G, Kalle AM, Pallu R, Alam MS (2012) Synthesis of novel 2-mercapto benzothiazole and 1,2,3-triazole based bis-heterocycles: their anti-inflammatory and anti-nociceptive activities. Eur J Med Chem 49:324–333. doi:10.1016/j.ejmech.2012.01.032
Shen J, Woodward R, Kedenburg JP, Liu X, Chen M, Fang L, Sun D, Wang PG (2008) Histone deacetylase inhibitors through click chemistry. J Med Chem 51(23):7417–7427. doi:10.1021/jm8005355
Simmons KJ, Chopra I, Fishwick CW (2010) Structure-based discovery of antibacterial drugs. Nat Rev Microbiol 8(7):501–510. doi:10.1038/nrmicro2349
Singh BK, Yadav AK, Kumar B, Gaikwad A, Sinha SK, Chaturvedi V, Tripathi RP (2008) Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents. Carbohydr Res 343(7):1153–1162. doi:10.1016/j.carres.2008.02.013
Thompson AM, Blaser A, Anderson RF, Shinde SS, Franzblau SG, Ma Z, Denny WA, Palmer BD (2009) Synthesis, reduction potentials, and antitubercular activity of ring A/B analogues of the bioreductive drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). J Med Chem 52(3):637–645. doi:10.1021/jm801087e
Tron GC, Pirali T, Billington RA, Canonico PL, Sorba G, Genazzani AA (2008) Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes. Med Res Rev 28(2):278–308. doi:10.1002/med.20107
van Maarseveen JH, Horne WS, Ghadiri MR (2005) Efficient route to C2 symmetric heterocyclic backbone modified cyclic peptides. Org Lett 7(20):4503–4506. doi:10.1021/ol0518028
Vantikommu J, Palle S, Reddy PS, Ramanatham V, Khagga M, Pallapothula VR (2010) Synthesis and cytotoxicity evaluation of novel 1,4-disubstituted 1,2,3-triazoles via CuI catalysed 1,3-dipolar cycloaddition. Eur J Med Chem 45(11):5044–5050. doi:10.1016/j.ejmech.2010.08.012
Velazquez S, Alvarez R, Perez C, Gago F, De Clercq E, Balzarini J, Camarasa MJ (1998) Regiospecific synthesis and anti-human immunodeficiency virus activity of novel 5-substituted N-alkylcarbamoyl and N,N-dialkylcarbamoyl 1,2,3-triazole-TSAO analogues. Antivir Chem Chemother 9(6):481–489
Wang X-L, Wan K, Zhou C-H (2010) Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities. Eur J Med Chem 45(10):4631–4639. doi:10.1016/j.ejmech.2010.07.031
Whiting M, Tripp JC, Lin Y-C, Lindstrom W, Olson AJ, Elder JH, Sharpless KB, Fokin VV (2006) Rapid discovery and structure−activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization. J Med Chem 49(26):7697–7710. doi:10.1021/jm060754+
Wright G (2014) Perspective: synthetic biology revives antibiotics. Nature 509(7498):S13. doi:10.1038/509S13a
Yim C-B, Dijkgraaf I, Merkx R, Versluis C, Eek A, Mulder GE, Rijkers DTS, Boerman OC, Liskamp RMJ (2010) Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed “click” cycloaddition and thio acid/sulfonyl azide “Sulfo-Click” amidation and their in vivo evaluation. J Med Chem 53(10):3944–3953. doi:10.1021/jm100246m
Acknowledgements
The authors thank the Department of Science and Technology (DST), New Delhi for support through grants SR/S1/IC-31/2011. NST thanks the University Grants Commission (UGC), New Delhi for a research fellowship.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Thirukovela, N.S., Kankala, S., Kankala, R.K. et al. Regioselective synthesis of some new 1,4-disubstituted sulfonyl-1,2,3-triazoles and their antibacterial activity studies. Med Chem Res 26, 2190–2195 (2017). https://doi.org/10.1007/s00044-017-1926-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-017-1926-6